Traditional concentration of reverse phase HPLC fractions to dryness in an evaporator is a fast and safe process. However, for certain compounds a fully dried result can be hard to achieve due to compound interactions with water boosting up the boiling point making drying difficult. Some compounds also tend to naturally form a gum or oils. This white paper explores how to avoid residual solvents and preventing the formation of gums and oils.

A study has found that the immune system plays a surprising role in the aftermath of heart attacks. The research could lead to new therapeutic strategies for heart disease.

Researchers have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer. In this study with a mouse model, researchers achieved a 100 percent cure rate--without any treatment-related toxic effects.

DNA Damage is ceaseless. The latest in DNA Damage/Genotoxicity Kits, detects seven proteins in this pathway, including important phosphorylation changes. This white paper demonstrates the utility in two cancer cell lines in which all analytes were detected with good specificity, sensitivity and precision.

A new Tel Aviv University study solves a critical piece of the puzzle of human deafness by identifying the first group of long non-coding RNAs (lncRNAs) in the auditory system.

A new family of multichannel electronic pipettes is closing the gap between traditional manual pipettes and robotic systems. This new video will provide you with an informative insight into how to improve your biological sample processing and collection.

Researchers from the University of Aberdeen, using pre-clinical mouse models, showed that just a single dose of the drug (Trodusquemine) completely reversed the effects of a disease that causes a host of heart problems.

A Science Translational Medicine study in nonhuman primates traces regeneration of blood and immune systems to 5 percent of transplanted blood stem cells.

An international team of researchers led by Johns Hopkins has shown that a topical gel made from a class of common blood pressure pills that block inflammation pathways speeds the healing of chronic skin wounds in mice and pigs.